Applied DNA Sciences (APDN) Competitors $3.48 -0.04 (-1.14%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$3.52 +0.04 (+1.15%) As of 08/22/2025 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APDN vs. BIAF, FTFT, PAVS, GMHS, ATXG, ZBAI, ONFO, MSPR, TGL, and PMAXShould you be buying Applied DNA Sciences stock or one of its competitors? The main competitors of Applied DNA Sciences include bioAffinity Technologies (BIAF), Future FinTech Group (FTFT), Paranovus Entertainment Technology (PAVS), Gamehaus (GMHS), Addentax Group (ATXG), ATIF (ZBAI), Onfolio (ONFO), MSP Recovery (MSPR), Treasure Global (TGL), and Powell Max (PMAX). These companies are all part of the "business services" industry. Applied DNA Sciences vs. Its Competitors bioAffinity Technologies Future FinTech Group Paranovus Entertainment Technology Gamehaus Addentax Group ATIF Onfolio MSP Recovery Treasure Global Powell Max bioAffinity Technologies (NASDAQ:BIAF) and Applied DNA Sciences (NASDAQ:APDN) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk. Do insiders and institutionals believe in BIAF or APDN? 1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 22.2% of Applied DNA Sciences shares are owned by institutional investors. 16.9% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 0.0% of Applied DNA Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer BIAF or APDN? In the previous week, bioAffinity Technologies had 3 more articles in the media than Applied DNA Sciences. MarketBeat recorded 3 mentions for bioAffinity Technologies and 0 mentions for Applied DNA Sciences. bioAffinity Technologies' average media sentiment score of 0.00 equaled Applied DNA Sciences'average media sentiment score. Company Overall Sentiment bioAffinity Technologies Neutral Applied DNA Sciences Neutral Which has more risk & volatility, BIAF or APDN? bioAffinity Technologies has a beta of 2.53, meaning that its stock price is 153% more volatile than the S&P 500. Comparatively, Applied DNA Sciences has a beta of -0.02, meaning that its stock price is 102% less volatile than the S&P 500. Do analysts recommend BIAF or APDN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Applied DNA Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher valuation and earnings, BIAF or APDN? Applied DNA Sciences has lower revenue, but higher earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than Applied DNA Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.36M0.77-$9.04M-$0.70-0.36Applied DNA Sciences$3.43M1.31-$6.99M-$923.810.00 Is BIAF or APDN more profitable? bioAffinity Technologies has a net margin of -152.16% compared to Applied DNA Sciences' net margin of -399.91%. Applied DNA Sciences' return on equity of -136.17% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-152.16% -845.68% -181.92% Applied DNA Sciences -399.91%-136.17%-101.95% SummarybioAffinity Technologies beats Applied DNA Sciences on 7 of the 13 factors compared between the two stocks. Get Applied DNA Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for APDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APDN vs. The Competition Export to ExcelMetricApplied DNA SciencesPROTECTION IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$4.49M$2.23B$7.74B$9.78BDividend YieldN/A1.81%4.55%4.05%P/E Ratio0.0020.4326.1226.05Price / Sales1.314.0799.57117.77Price / CashN/A72.9528.6259.36Price / Book0.644.084.106.60Net Income-$6.99M$110.39M$796.69M$265.65M7 Day Performance-11.00%1.46%0.70%2.01%1 Month Performance-33.84%-3.44%0.55%-0.33%1 Year Performance-99.82%21.35%26.92%19.04% Applied DNA Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APDNApplied DNA Sciences0.0697 of 5 stars$3.48-1.1%N/A-99.7%$4.49M$3.43M0.0070Short Interest ↑BIAFbioAffinity Technologies0.5175 of 5 stars$0.25+5.1%N/A-85.4%$6.63M$9.36M-0.3510News CoverageGap UpFTFTFuture FinTech Group1.0893 of 5 stars$1.83-3.2%N/A-32.2%$6.52M$2.16M0.0070Earnings ReportGap UpPAVSParanovus Entertainment TechnologyN/A$0.74-4.1%N/A-31.7%$5.65M$70K0.00220Positive NewsGMHSGamehausN/A$1.22-0.8%N/AN/A$5.58M$145.24M0.00N/APositive NewsATXGAddentax Group0.4505 of 5 stars$0.47-1.1%N/A-21.5%$5.56M$4.18M-0.67130News CoverageAnalyst UpgradeGap DownZBAIATIFN/A$5.54-3.7%N/AN/A$5.54M$620K-0.7710Positive NewsAnalyst UpgradeONFOOnfolio0.9955 of 5 stars$1.06+1.9%N/A+5.7%$5.33M$7.86M-2.598News CoverageMSPRMSP RecoveryN/A$0.53-11.4%N/AN/A$4.95M$18.25M0.003Gap DownTGLTreasure Global0.4204 of 5 stars$1.50+18.1%N/A-97.9%$4.84M$22.07M0.0050High Trading VolumePMAXPowell MaxN/A$0.32-1.2%N/AN/A$4.76M$4.69M0.00N/A Related Companies and Tools Related Companies bioAffinity Technologies Competitors Future FinTech Group Competitors Paranovus Entertainment Technology Competitors Gamehaus Competitors Addentax Group Competitors ATIF Competitors Onfolio Competitors MSP Recovery Competitors Treasure Global Competitors Powell Max Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APDN) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied DNA Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied DNA Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access